Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

• Status: Completed
• Trial end date: 2009-01-01

Summary

The purpose is to study if HF treatment guided by NTproBNP in addition to clinical symptoms and signs is more effective than treatment guided by clinical symptoms and signs alone in patients with HF and left ventricular systolic dysfunction

• Phase: Phase 4

Details

• Lead Sponsor: AstraZeneca
• Treatments: Bisoprolol; Candesartan; Captopril; Carvedilol; Diuretics; Enalapril; Eplerenone; Lisinopril; Metoprolol; Natriuretic Peptide, Brain; Ramipril; Spironolactone; Trandolapril; Valsartan